Island Pharma Jumps After Emergency-Use Approval for Ebola Drug

This is a live story built from multiple sources. It may evolve quickly.

Coverage meter • 1 min window

Back to home Open top source

B bloomberg.com

What’s included

Top recent items from this story.

1 items • 1 unique links

Bloomberg Markets 2 hours ago • bloomberg.com

Island Pharma Jumps After Emergency-Use Approval for Ebola Drug

Australia’s Island Pharmaceuticals Ltd. surged as much as 47% after saying its experimental antiviral galidesivir had secured regulatory and ethics approvals for emergency use in patients with the Bundibugyo strain of Eb…

Open